NextFin News -
Pre-Market Performance
U.S. index futures were mixed, with technology weakness weighing on Nasdaq-linked contracts while Dow futures held in positive territory. Nasdaq 100 futures traded at 29,456.00, down 237.25 points, or 0.80%. S&P 500 futures were at 7,598.50, down 16.25 points, or 0.21%. Dow Jones futures rose 90.00 points, or 0.17%, to 52,990.00.
European markets were broadly lower. The FTSE 100 slipped 24.61 points, or 0.23%, to 10,491.31. France’s CAC 40 fell 82.18 points, or 0.98%, to 8,300.25. Germany’s DAX dropped 229.84 points, or 0.92%, to 24,769.69.
In commodities and currencies, energy remained firm as geopolitical risk stayed in focus. WTI crude traded around $80.04, up $0.44, or 0.55%, while Brent crude was near $85.21, up $0.26, or 0.31%. Gold futures fell $15.53, or 0.38%, to $4,036.27. The U.S. Dollar Index edged up 0.066, or 0.07%, to 100.34. Natural gas rose 0.38% to $2.935, and copper gained 0.87% to $6.396.
Hot News
- U.S. futures mixed as chip weakness weighs: Nasdaq futures lagged as investors sold semiconductor and AI-hardware names despite strong headline earnings from Taiwan Semiconductor Manufacturing. Pre-market pressure showed up in chip-linked names including Micron, Intel, AMD, Western Digital and Seagate.
- Middle East tensions and earnings keep European markets cautious: Oil remained a key variable amid renewed U.S.-Iran hostilities and potential shipping-route disruptions, keeping energy-sensitive sectors and airlines under scrutiny while investors weighed corporate results.
- Earnings season helps offset risk pressure: Strong reports from select healthcare and financial names helped cushion Dow futures, with UnitedHealth’s raised guidance notable; the market remained selective, rewarding beats and punishing stretched valuations or margin concerns.
- AI trade faces a valuation reset: TSMC’s record quarter confirmed robust AI demand, but the stock moved lower pre-market as investors focused on sharply higher capital spending and potential margin pressure, reinforcing caution around high-multiple AI infrastructure names.
U.S. Stock Focus
- UnitedHealth — Shares jump after earnings beat and raised guidance: UnitedHealth reported adjusted EPS of $6.38, above consensus of $4.85, on revenue of $112.0 billion versus expectations of $110.76 billion. The company lifted its 2026 adjusted EPS outlook to $19.50–$20.00, and shares rose about 5.85% pre-market to around $443.00.
- Taiwan Semiconductor Manufacturing — Record profit, but ADRs fall: TSMC posted Q2 net profit of T$706.6 billion (about $21.99 billion), up 77% year over year, with Q2 revenue of $40.2 billion. Despite the beat, U.S.-listed shares were indicated about 3%–4% lower as investors focused on a higher 2026 capital spending budget of $60 billion–$64 billion.
- United Airlines — Earnings beat overshadowed by fuel-cost pressure: United reported adjusted EPS of $1.99 and revenue of $17.67 billion, topping estimates, but shares fell about 2.5% in pre-open trading after the company warned higher fuel prices could add nearly $6 billion in costs and gave a softer Q3 outlook.
- Progressive — Profit beat fails to lift shares: Progressive reported Q2 EPS of $5.67, above consensus of $4.73, and revenue of $21.57 billion. Shares fell about 4% pre-market as investors focused on a modest deterioration in underwriting profitability, with the combined ratio worsening to 87.3 from 86.2 a year earlier.
- Abbott Laboratories — Stock rises after healthcare results beat: Abbott traded sharply higher after Q2 results beat expectations, with EPS of $1.31 versus $1.28 expected and revenue of $12.59 billion versus $12.52 billion expected. Investors also focused on signs that continuous glucose monitoring sales are on track to return to double-digit growth.
- U.S. Bancorp — Record quarterly revenue on loan growth and BTIG contribution: U.S. Bancorp reported total net revenue of $7.71 billion, up 10.1%, and profit attributable to the bank rose 20% to $2.18 billion. Net interest income climbed 7.7% to $4.36 billion, while capital markets revenue surged 62.5% to $512 million following the BTIG acquisition.
- J.B. Hunt — Transport stock rallies after Q2 beat: J.B. Hunt reported Q2 revenue of $3.50 billion, up 19% year over year, and EPS of $1.91, up from $1.31 a year earlier. Intermodal revenue rose 22% to $1.75 billion, and shares gained about 7.35% pre-market to around $296.60.
- Eli Lilly and AtaiBeckley — Lilly agrees deal worth up to $3.8 billion: Eli Lilly will acquire AtaiBeckley for up to $3.8 billion, including $2.8 billion upfront and up to $1.0 billion in milestone payments, at $6.75 per share — a premium of about 26% that sent AtaiBeckley shares more than 30% higher pre-market.
- AST SpaceMobile — Shares fall after $1 billion convertible-note pricing: AST SpaceMobile priced a private offering of $1.0 billion of 1.625% convertible senior notes due 2034, with an initial conversion price of about $79.57 per Class A share; shares were down about 10% in pre-market trading.
Explore more exclusive insights at nextfin.ai.
